A carregar...
Adenosine A(2A) receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease
BackgroundWe evaluated the efficacy and safety of istradefylline, a selective adenosine A(2A) receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks in a double-blind manner in Parkinson’s disease patients with motor complications in Japan. MethodsA total of 373 subjects w...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3842830/ https://ncbi.nlm.nih.gov/pubmed/23483627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25418 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|